Virpax Pharmaceuticals, Inc. (VRPX)
OTCMKTS · Delayed Price · Currency is USD
0.0110
-0.0100 (-47.62%)
Oct 7, 2025, 3:04 PM EDT
Virpax Pharmaceuticals Market Cap
Virpax Pharmaceuticals has a market cap or net worth of $13.67 thousand as of October 7, 2025. Its market cap has decreased by -99.63% in one year.
Market Cap
13.67K
Enterprise Value
-1.50M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since February 17, 2021, Virpax Pharmaceuticals's market cap has decreased from 32.29M to 13.67K, a decrease of -99.96%. That is a compound annual growth rate of -81.26%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 13.67K | -99.56% |
| Dec 31, 2024 | 3.07M | -18.06% |
| Dec 29, 2023 | 3.75M | -48.56% |
| Dec 30, 2022 | 7.29M | -81.86% |
| Dec 31, 2021 | 40.18M | 24.44% |
| Feb 17, 2021 | 32.29M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Elite Pharmaceuticals | 674.12M |
| Glass House Brands | 644.95M |
| Veradigm | 511.83M |
| Northwest Biotherapeutics | 380.49M |
| Nika Pharmaceuticals | 333.67M |
| CytoDyn | 321.63M |
| American Oncology Network | 273.17M |
| Silence Therapeutics | 245.14M |